M1巨细胞作为子宫内膜异位症细胞治疗的有希望的药物

Daria Artemova1,2, Polina Vishnyakova2,3, Andrey Elchaninov1,2,3

  • 1Avtsyn Research Institute of Human Morphology of Federal State Budgetary Scientific Institution "Petrovsky National Research Centre of Surgery", 3 Tsurupa Street, 117418, Moscow, Russian Federation.

Heliyon
|September 10, 2024
PubMed
概括

使用M1巨细胞的细胞疗法在治疗子宫内膜异位症方面表现有前途. 这种微创手术方法通过重编程M1巨细胞来减少子宫内膜异位病变的大小和数量,提供了一种新的治疗策略.